A possible beneficial effect of Bacteroides on faecal lipopolysaccharide activity and cardiovascular diseases

[1]  Marco Piñón,et al.  I Overview , 2020, The Diaries and Letters of Lord Woolton 1940-1945.

[2]  K. Hirata,et al.  Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease , 2019, Journal of atherosclerosis and thrombosis.

[3]  D. Gori,et al.  Effect of Adherence to Mediterranean Diet during Pregnancy on Children’s Health: A Systematic Review , 2019, Nutrients.

[4]  Takuji Yamada,et al.  Gut Microbiome and Plasma Microbiome-Related Metabolites in Patients With Decompensated and Compensated Heart Failure. , 2018, Circulation journal : official journal of the Japanese Circulation Society.

[5]  J. Schrenzel,et al.  Functional Gut Microbiota Remodeling Contributes to the Caloric Restriction-Induced Metabolic Improvements , 2018, Cell metabolism.

[6]  Takuji Yamada,et al.  Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis , 2018, Circulation.

[7]  M. McCarter,et al.  Fecal Microbiota Composition Drives Immune Activation in HIV-infected Individuals , 2018, EBioMedicine.

[8]  A. Kondo,et al.  Low amounts of dietary fibre increase in vitro production of short-chain fatty acids without changing human colonic microbiota structure , 2018, Scientific Reports.

[9]  M. Gillilland,et al.  FODMAP diet modulates visceral nociception by lipopolysaccharide-mediated intestinal inflammation and barrier dysfunction , 2017, The Journal of clinical investigation.

[10]  T. Cullen,et al.  Total Lipopolysaccharide from the Human Gut Microbiome Silences Toll-Like Receptor Signaling , 2017, mSystems.

[11]  A. Sannino,et al.  Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis , 2017, European heart journal.

[12]  Xun Xu,et al.  The gut microbiome in atherosclerotic cardiovascular disease , 2017, Nature Communications.

[13]  Huijue Jia,et al.  Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention , 2017, Nature Medicine.

[14]  Jin-Ju Jeong,et al.  Gastrointestinal inflammation by gut microbiota disturbance induces memory impairment in mice , 2017, Mucosal Immunology.

[15]  F. Violi,et al.  Gut‐Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet , 2017, Journal of the American Heart Association.

[16]  A. Goodman,et al.  An insider's perspective: Bacteroides as a window into the microbiome , 2017, Nature Microbiology.

[17]  Y. Saeki,et al.  Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine , 2016, Arthritis & rheumatology.

[18]  P. Bork,et al.  Human gut microbes impact host serum metabolome and insulin sensitivity , 2016, Nature.

[19]  Eric A. Franzosa,et al.  Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans , 2016, Cell.

[20]  Dong-Hyun Kim,et al.  Gut microbiota lipopolysaccharide accelerates inflamm-aging in mice , 2016, BMC Microbiology.

[21]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[22]  P. Adam,et al.  Endotoxicity of lipopolysaccharide as a determinant of T-cell-mediated colitis induction in mice. , 2014, Gastroenterology.

[23]  Hiroshi Mori,et al.  Design and Experimental Application of a Novel Non-Degenerate Universal Primer Set that Amplifies Prokaryotic 16S rRNA Genes with a Low Possibility to Amplify Eukaryotic rRNA Genes , 2013, DNA research : an international journal for rapid publication of reports on genes and genomes.

[24]  M. Tomita,et al.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2013, Nature.

[25]  Qiang Feng,et al.  A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.

[26]  Katherine H. Huang,et al.  Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.

[27]  Brian J. Bennett,et al.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.

[28]  J. Doré,et al.  Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. , 2009, FEMS microbiology ecology.

[29]  K. Schleifer,et al.  The All-Species Living Tree project: a 16S rRNA-based phylogenetic tree of all sequenced type strains. , 2008, Systematic and applied microbiology.

[30]  R. Munford.  Sensing Gram-Negative Bacterial Lipopolysaccharides: a Human Disease Determinant? , 2007, Infection and Immunity.

[31]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[32]  Michael Böhm,et al.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Journal of hypertension.

[33]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[34]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[35]  A. Weintraub,et al.  Bacteroides fragilis-Derived Lipopolysaccharide Produces Cell Activation and Lethal Toxicity via Toll-Like Receptor 4 , 2005, Infection and Immunity.

[36]  Stephan von Haehling,et al.  Inflammatory mediators in chronic heart failure: an overview , 2004, Heart.

[37]  K. Hirata,et al.  Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase. , 2000, Circulation.

[38]  S. Kiechl,et al.  Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[39]  S. Kiechl,et al.  Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. , 1999, Journal of the American College of Cardiology.

[40]  K. Bailey,et al.  Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. , 1998, Circulation.

[41]  I. Poxton,et al.  Biological activity of Bacteroides lipopolysaccharide--reappraisal. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  A. Kondo,et al.  A Single-Batch Fermentation System to Simulate Human Colonic Microbiota for High-Throughput Evaluation of Prebiotics. , 2016, PloS one.

[43]  P. Kirchhof,et al.  The task force for the management ofarterial hypertension of the european society ofhypertension (esh) and of the european society of cardiology (esc) , 2013 .

[44]  Helmut Baumgartner,et al.  The 2013 ESH/ESC guidelines for the management of arterial hypertension , 2013 .

[45]  R. Alizadeh,et al.  Extraction, Purification and Characterization of Lipopolysaccharide from Escherichia coli and Salmonella typhi , 2011, Avicenna journal of medical biotechnology.